Immunicon
Industry · 2 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Unknown | Circulating Tumor Cells and Survival in Hormone Refractory Prostate Cancer (HRPC) Patients Receiving Chemother Hormone Refractory Prostate Cancer, Prostate Cancer | — | 2004-12-01 |
| Unknown | Circulating Tumor Cells in Patients With Metastatic Colorectal Cancer Colorectal Cancer, Neoplasm Metastasis | — | 2004-03-01 |